Buy Gsk Shares – Ad-Free

: Strong market position with Shingrix (shingles) and Arexvy (RSV).

: Settled ~93% (80,000 cases) of U.S. Zantac litigation for $2.2 billion, removing a major long-term overhang. ⚠️ Risks to Consider Stock Story: GSK - The Merchants Trust buy gsk shares

: Trades at ~10.3x to 14.5x 2026 adjusted earnings. : Strong market position with Shingrix (shingles) and

: 3.2% to 3.5% (annualized ~70p expected for 2026). Market Cap : ~£110 Billion. 📈 Investment Thesis: Why Buy? buy gsk shares

: Five major product approvals were achieved in 2025; two more expected in 2026 for bepirovirsen and tebipenem .